Avantor, Inc. (AVTR) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $8.20. It has a SharesGrow Score of 48/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of AVTR = $16.22 (+97.8% from the current price, the stock appears undervalued). Analyst consensus target is AVTR = $10 (+19.4% upside).
Valuation: AVTR trades at a trailing Price-to-Earnings (P/E) of -10 (S&P 500 average ~25).
Financials: revenue is $6.6B, -4.4%/yr average growth. Net income is $530M (loss), growing at -35.4%/yr. Net profit margin is -8.1% (negative). Gross margin is 32.7% (-1.9 pp trend).
Balance sheet: total debt is $3.9B against $5.6B equity (Debt-to-Equity (D/E) ratio 0.71, moderate). Current ratio is 1.78 (strong liquidity). Debt-to-assets is 33.5%. Total assets: $11.8B.
Analyst outlook: 9 / 26 analysts rate AVTR as buy (35%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 86/100 (Pass), Growth 15/100 (Fail), Past 75/100 (Partial), Health 50/100 (Partial), Moat 56/100 (Partial), Future 46/100 (Partial), Income 10/100 (Fail).
